241 related articles for article (PubMed ID: 33513955)
1. Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase.
Jończyk J; Kukułowicz J; Łątka K; Malawska B; Jung YS; Musilek K; Bajda M
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33513955
[TBL] [Abstract][Full Text] [Related]
2. Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase.
Kovarik Z; Maček Hrvat N; Kalisiak J; Katalinić M; Sit RK; Zorbaz T; Radić Z; Fokin VV; Sharpless KB; Taylor P
Toxicol Appl Pharmacol; 2019 Jun; 372():40-46. PubMed ID: 30978400
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.
Maček Hrvat N; Kalisiak J; Šinko G; Radić Z; Sharpless KB; Taylor P; Kovarik Z
Toxicol Lett; 2020 Mar; 321():83-89. PubMed ID: 31863869
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic studies of new oximes reactivators of human butyryl cholinesterase inhibited by cyclosarin and sarin.
de Lima WE; Francisco A; da Cunha EF; Radic Z; Taylor P; França TC; Ramalho TC
J Biomol Struct Dyn; 2017 May; 35(6):1272-1282. PubMed ID: 27125569
[TBL] [Abstract][Full Text] [Related]
5. Enantioseparation, in vitro testing, and structural characterization of triple-binding reactivators of organophosphate-inhibited cholinesterases.
Maraković N; Knežević A; Rončević I; Brazzolotto X; Kovarik Z; Šinko G
Biochem J; 2020 Aug; 477(15):2771-2790. PubMed ID: 32639532
[TBL] [Abstract][Full Text] [Related]
6. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
[TBL] [Abstract][Full Text] [Related]
7. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
Scheffel C; Thiermann H; Worek F
Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
[TBL] [Abstract][Full Text] [Related]
8. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds.
Bušić V; Katalinić M; Šinko G; Kovarik Z; Gašo-Sokač D
Toxicol Lett; 2016 Nov; 262():114-122. PubMed ID: 27693733
[TBL] [Abstract][Full Text] [Related]
9. Oxime-mediated in vitro reactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase.
Sahu AK; Sharma R; Gupta B; Musilek K; Kuca K; Acharya J; Ghosh KK
Toxicol Mech Methods; 2016 Jun; 26(5):319-26. PubMed ID: 27101948
[TBL] [Abstract][Full Text] [Related]
10. The reactivation kinetic analysis, molecular docking, and dynamics of oximes against three V-type nerve agents inhibited four human cholinesterases.
Li K; Liu Y; Liu Y; Li Q; Guo L; Xie J
Chem Biol Interact; 2024 Jun; 396():111061. PubMed ID: 38763347
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
12. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
[TBL] [Abstract][Full Text] [Related]
13. Synthesis,
Malinak D; Dolezal R; Hepnarova V; Hozova M; Andrys R; Bzonek P; Racakova V; Korabecny J; Gorecki L; Mezeiova E; Psotka M; Jun D; Kuca K; Musilek K
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):478-488. PubMed ID: 31910701
[TBL] [Abstract][Full Text] [Related]
14. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase.
Kovarik Z; Katalinić M; Sinko G; Binder J; Holas O; Jung YS; Musilova L; Jun D; Kuca K
Chem Biol Interact; 2010 Sep; 187(1-3):167-71. PubMed ID: 20206154
[TBL] [Abstract][Full Text] [Related]
15. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.
Ghosh S; Chandar NB; Jana K; Ganguly B
J Comput Aided Mol Des; 2017 Aug; 31(8):729-742. PubMed ID: 28646405
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon.
Kuca K; Jun D; Junova L; Musilek K; Hrabinova M; da Silva JAV; Ramalho TC; Valko M; Wu Q; Nepovimova E; França TCC
Molecules; 2018 May; 23(5):. PubMed ID: 29735900
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol Oxime Olesoxime Assessed as a Potential Ligand of Human Cholinesterases.
Kolić D; Šinko G; Jean L; Chioua M; Dias J; Marco-Contelles J; Kovarik Z
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785995
[TBL] [Abstract][Full Text] [Related]
18. In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesterase.
Jun D; Musilova L; Musilek K; Kuca K
Int J Mol Sci; 2011; 12(3):2077-87. PubMed ID: 21673941
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling and in vitro reactivation study between the oxime BI-6 and acetylcholinesterase inhibited by different nerve agents.
Giacoppo JO; C C França T; Kuča K; da Cunha EF; Abagyan R; Mancini DT; Ramalho TC
J Biomol Struct Dyn; 2015 Sep; 33(9):2048-58. PubMed ID: 25407587
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
